Co-Transplantation of Pancreatic Islet Cells and Mesenchymal Bone Marrow Precursors on Titanium Nickelide Scaffolds in Alloxan-Induced Diabetes Mellitus
- 14 Downloads
We studied therapeutic activity of co-transplantation of allogeneic pancreatic islet cells and mesenchymal bone marrow progenitors on TiNi scaffolds in Wistar rats with experimental alloxan-induced diabetes mellitus. In preliminary experiments with co-culturing of cells in different proportions followed by their transplantation on tissue-engineered constructs, the optimum ratio of these cells was determined — 3:1. Regeneration was assessed by biochemical methods by the blood levels of glucose and glycosylated hemoglobin on days 15, 30, and 5. In the group with combined cell transplantation on TiNi scaffold, normalization of the studied biochemical parameters occurred earlier than after monotherapy with allogenic islet cells and was associated with an increase in animal lifespan. Normalization of the parameters of bone marrow hemopoiesis, in particular, the number of myelokaryocytes and erythroblasts was also noted.
Key Wordstissue engineering diabetes mellitus pancreatic islet cells mesenchymal stem cells porous TiNi
Unable to display preview. Download preview PDF.
- 2.Vladimirskaya EB. Mesenchymal stem cells (MSCs) in cell therapy. Onkogematologiya. 2007;2(1):4-16. Russian.Google Scholar
- 4.Khubutiya MSh, Vagabov VA, Temnov AA, Sklifas AN. Paracrine mechanisms of antiinflammatory and organoprotective effectsin MBMPC transplantation. Transplantologiya. 2012;(1-2):20-32. Russian.Google Scholar
- 5.Khulup GYa, Mastistkaya SYu, Zafranskaya MM, Lamovskaya NV, Nizhegorodova DB, Ivanchik GI, Deneke B. Differentiation and immunomodulatory properties of mesenchymal stem cells as potential mechanisms of their positive effect in myocardial infarction. Vestn. Vitebsk. Gos. Med. Univer. 2009;8(1):12-21. Russian.Google Scholar
- 6.Shakhov VP, Khlusov IA, Dambaev GTs, Zaitsev KV, Salmina AB, Shakhova SS, Zagrebin LV, Volgushev SA. Introduction into Methods of Cell Culture and Bioengineering of Organs and Tissues. Tomsk, 2004. Russian.Google Scholar
- 8.Basta G, Montanucci P, Luca G, Boselli C, Noya G, Barbaro B, Qi M, Kinzer KP, Oberholzer J, Calafiore R. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts. Diabetes Care. 2011;34(11):2406-2409.CrossRefGoogle Scholar
- 9.El-Badri N, Ghoneim MA. Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges. J. Nucleic Acids. 2013;2013. ID 194858. doi: https://doi.org/10.1155/2013/194858.
- 12.Stull ND, Breite A, McCarthy R, Tersey SA, Mirmira RG. Mouse islet of langerhans isolation using a combination of purified collagenase and neutral protease. J. Vis. Exp. 2012;(67). pii: 4137. doi: https://doi.org/10.3791/4137.